INTEGRATED BIOPHARMA INC (INBP) SEC filings
INBP SEC filings moved a median of 0.00% by the close. INBP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the INBP overview →
34 measured INBP SEC filing events.
Where these INBP SEC filings landedvs 27 measured INBP SEC filing reactions
| Middle 50% of INBP SEC filing reactions | -0.12% to +9.58% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 INBP SEC filing events with a measured close landed between -0.12% and +9.58%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 10-K | -0.66% | -6.75% | |
| Form 8-K INTEGRATED BIOPHARMA For: Sep 25 | SEC filing · Form 8-K | -0.66% | -6.75% | |
| Form 8-K INTEGRATED BIOPHARMA For: Aug 20 | SEC filing · Form 8-K | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 8-K | — | — | |
| Form 10-Q INTEGRATED BIOPHARMA For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: May 08 | SEC filing · Form 8-K | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: Apr 14 | SEC filing · Form 8-K | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 17 | SEC filing · Form 8-K | +0.00% | -2.46% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Dec 31 | SEC filing · Form 10-Q | +2.14% | +10.68% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 11 | SEC filing · Form 8-K | +2.14% | +10.68% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Sep 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 10 | SEC filing · Form 8-K | — | +0.00% | |
| Form DEF 14A INTEGRATED BIOPHARMA For: Oct 28 | SEC filing · Form DEF | — | — | |
| Form 10-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 10-K | — | +17.86% | |
| Form 8-K INTEGRATED BIOPHARMA For: Sep 23 | SEC filing · Form 8-K | — | +10.52% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Mar 31 | SEC filing · Form 10-Q | +4.17% | +3.91% | |
| Form 8-K INTEGRATED BIOPHARMA For: May 14 | SEC filing · Form 8-K | — | -0.24% | |
| Form 8-K INTEGRATED BIOPHARMA For: Apr 24 | SEC filing · Form 8-K | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: Apr 15 | SEC filing · Form 8-K | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 13 | SEC filing · Form 8-K | -5.96% | -10.55% | |
| Form 8-K INTEGRATED BIOPHARMA For: Dec 02 | SEC filing · Form 8-K | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 13 | SEC filing · Form 8-K | +0.00% | +6.00% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Sep 30 | SEC filing · Form 10-Q | -1.49% | +4.48% | |
| Form DEF 14A INTEGRATED BIOPHARMA For: Oct 28 | SEC filing · Form DEF | +0.00% | +0.46% | |
| Form 8-K INTEGRATED BIOPHARMA For: Sep 20 | SEC filing · Form 8-K | — | +0.00% | |
| Form 10-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 10-K | +0.00% | +8.65% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +20.16% | |
| Form 8-K INTEGRATED BIOPHARMA For: May 10 | SEC filing · Form 8-K | +0.00% | +20.16% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Dec 31 | SEC filing · Form 10-Q | +0.00% | -4.76% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 12 | SEC filing · Form 8-K | +0.00% | -4.76% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 27 | SEC filing · Form 8-K | — | +0.00% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +17.39% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 09 | SEC filing · Form 8-K | — | +0.00% | |
| Form DEF 14A INTEGRATED BIOPHARMA For: Oct 27 | SEC filing · Form DEF | — | — |
Keep exploring
More INBP: earnings → · analyst actions → · INBP overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Flurotech Ltd (TEST_CDNX) | 87 | 0.00% | 41% |
| Agile Therapeutics, Inc. (AGRX) | 86 | 0.00% | 41% |
| NORTHWEST BIOTHRPUTCS INC (NWBO) | 86 | -0.49% | 41% |
| SWEDISH ORPHAN ADR (SWTUY) | 86 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.